Hyperlipidemia as a risk factor for cardiovascular disease
RH Nelson - Primary Care: Clinics in Office Practice, 2013 - primarycare.theclinics.com
Modern primary care practitioners spend considerable time and effort on preventive
medicine. Diagnosing and managing hyperlipidemia as a way to prevent cardiovascular …
medicine. Diagnosing and managing hyperlipidemia as a way to prevent cardiovascular …
PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future
YJ Shimada, CP Cannon - European heart journal, 2015 - academic.oup.com
Reduction in low-density lipoprotein cholesterol (LDL-C), mainly with statins, has decreased
the risk of cardiovascular events over the last few decades. However, there are several …
the risk of cardiovascular events over the last few decades. However, there are several …
[PDF][PDF] Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection
Purpose Statins may have protective effects against cancer, but no studies have focused on
their effects in patients with chronic hepatitis C virus (HCV) infection. The purpose of this …
their effects in patients with chronic hepatitis C virus (HCV) infection. The purpose of this …
[HTML][HTML] Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China
Background Lifestyle and dietary changes reflect an ongoing epidemiological transition in
China, with cardiovascular disease (CVD) playing an ever-increasing role in China's …
China, with cardiovascular disease (CVD) playing an ever-increasing role in China's …
Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
JG Robinson - Journal of Managed Care Pharmacy, 2013 - jmcp.org
Familial hypercholesterolemia (FH) is a genetic disorder of lipid metabolism that is
characterized by a significant elevation in levels of low-density lipoprotein cholesterol (LDL …
characterized by a significant elevation in levels of low-density lipoprotein cholesterol (LDL …
Cataract surgery cost utility revisited in 2012: a new economic paradigm
GC Brown, MM Brown, A Menezes, BG Busbee… - Ophthalmology, 2013 - Elsevier
Objective To assess the 2012 cost utility of cataract surgery in the United States and to
compare 2012 cost-utility data with those from 2000. Design Value-Based Medicine …
compare 2012 cost-utility data with those from 2000. Design Value-Based Medicine …
Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage …
A McConnachie, A Walker, M Robertson… - European heart …, 2014 - academic.oup.com
Aims To assess the impact on healthcare resource utilization, costs, and quality of life over
15 years from 5 years of statin use in men without a history of myocardial infarction in the …
15 years from 5 years of statin use in men without a history of myocardial infarction in the …
Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery: a review
BA De Waal, MP Buise… - British journal of …, 2015 - academic.oup.com
Statins feature documented benefits for primary and secondary prevention of cardiovascular
disease and are thought to improve perioperative outcomes in patients undergoing surgery …
disease and are thought to improve perioperative outcomes in patients undergoing surgery …
[PDF][PDF] Self-reported financial barriers to care among patients with cardiovascular-related chronic conditions
DJ Campbell, K King-Shier, BR Hemmelgarn… - Health …, 2014 - researchgate.net
Background People with chronic conditions who do not achieve therapeutic targets have a
higher risk of adverse health outcomes. Failure to meet these targets may be due to a variety …
higher risk of adverse health outcomes. Failure to meet these targets may be due to a variety …
Canadian Cost-Effectiveness of Coronary Artery Calcium Screening Based on the Multi-Ethnic Study of Atherosclerosis
Background Cost-effectiveness of testing for coronary artery calcium (CAC) relative to other
treatment strategies is not established in Canada. Objectives The purpose of this study was …
treatment strategies is not established in Canada. Objectives The purpose of this study was …